NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share (NAMS)

79 filings reported holding NAMS - NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share as of Q1 2024.
NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share (NAMS) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 72.2M shares of 112M outstanding shares and own 64.28% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (12.2M shares), FCPM III SERVICES B.V. (11.8M shares), Bain Capital Life Sciences Investors, LLC (10.5M shares), VIKING GLOBAL INVESTORS LP (8.02M shares), RA CAPITAL MANAGEMENT, L.P. (7.86M shares), Medicxi Ventures Management (Jersey) Ltd (2.87M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.82M shares), BVF INC/IL (1.52M shares), Cormorant Asset Management, LP (1.5M shares), and GOLDMAN SACHS GROUP INC (1.28M shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.